Cargando…
PAK4 confers the malignance of cervical cancers and contributes to the cisplatin-resistance in cervical cancer cells via PI3K/AKT pathway
BACKGROUND: Multiple protein or microRNA markers have been recognized to contribute to the progression and recurrence of cervical cancers. Particular those, which are associated with the chemo- or radio-resistance of cervical cancers, have been proposed to be promising and to facilitate the definiti...
Autores principales: | Shu, Xiang-Rong, Wu, Jing, Sun, He, Chi, Li-Qun, Wang, Jin-Huan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584462/ https://www.ncbi.nlm.nih.gov/pubmed/26411419 http://dx.doi.org/10.1186/s13000-015-0404-z |
Ejemplares similares
-
PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways
por: Fu, Xueqiong, et al.
Publicado: (2014) -
Synergistic effects of thalidomide and cisplatin are mediated via the PI3K/AKT and JAK1/STAT3 signaling pathways in cervical cancer
por: Liu, Cairu, et al.
Publicado: (2022) -
Activated-PAK4 predicts worse prognosis in breast cancer and promotes tumorigenesis through activation of PI3K/AKT signaling
por: He, Li-Fang, et al.
Publicado: (2016) -
PAK5 Induces EMT and Promotes Cell Migration and Invasion by Activating the PI3K/AKT Pathway in Ovarian Cancer
por: Li, Diyou, et al.
Publicado: (2018) -
MicroRNA-98-5p modulates cervical cancer progression via controlling PI3K/AKT pathway
por: Xiao, RongXin, et al.
Publicado: (2021)